FI763391A - - Google Patents

Info

Publication number
FI763391A
FI763391A FI763391A FI763391A FI763391A FI 763391 A FI763391 A FI 763391A FI 763391 A FI763391 A FI 763391A FI 763391 A FI763391 A FI 763391A FI 763391 A FI763391 A FI 763391A
Authority
FI
Finland
Application number
FI763391A
Other versions
FI64359B (fi
FI64359C (fi
Inventor
Gianfederico Doria
Ciriaco Romeo
Piernicola Giraldi
Francesco Lauria
Maria Luisa Corno
Piero Sberze
Marcello Tibolla
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI763391A publication Critical patent/FI763391A/fi
Publication of FI64359B publication Critical patent/FI64359B/fi
Application granted granted Critical
Publication of FI64359C publication Critical patent/FI64359C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/93Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI763391A 1975-12-05 1976-11-25 Analogifoerfarande foer framstaellning av terapeutiskt verksamma 3,4-dihydro-4-oxo-kinazolinderivat FI64359C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2999875 1975-12-05
IT29998/75A IT1050750B (it) 1975-12-05 1975-12-05 Derivati della 3.4 di idro chinazolina

Publications (3)

Publication Number Publication Date
FI763391A true FI763391A (fi) 1977-06-06
FI64359B FI64359B (fi) 1983-07-29
FI64359C FI64359C (fi) 1983-11-10

Family

ID=11228830

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763391A FI64359C (fi) 1975-12-05 1976-11-25 Analogifoerfarande foer framstaellning av terapeutiskt verksamma 3,4-dihydro-4-oxo-kinazolinderivat

Country Status (22)

Country Link
US (1) US4251531A (fi)
JP (1) JPS5271485A (fi)
AT (1) AT355029B (fi)
AU (1) AU505660B2 (fi)
BE (1) BE848696A (fi)
CA (1) CA1084051A (fi)
CH (2) CH626073A5 (fi)
CS (1) CS194786B2 (fi)
DE (1) DE2654215A1 (fi)
DK (1) DK147855C (fi)
FI (1) FI64359C (fi)
FR (1) FR2333511A1 (fi)
GB (1) GB1523081A (fi)
HU (1) HU177817B (fi)
IL (1) IL50849A (fi)
IT (1) IT1050750B (fi)
NL (1) NL7613450A (fi)
NO (1) NO146095C (fi)
NZ (1) NZ182778A (fi)
SE (1) SE7613588L (fi)
SU (1) SU786894A3 (fi)
ZA (1) ZA766745B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES524262A0 (es) * 1982-08-05 1984-11-16 Erba Farmitalia "procedimiento para preparar derivados de quinazolina"
JPS5925224U (ja) * 1982-08-10 1984-02-16 株式会社根来 かばん
US4666913A (en) * 1985-11-22 1987-05-19 William H. Rorer, Inc. Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
GB8827988D0 (en) * 1988-11-30 1989-01-05 Smith Kline French Lab Chemical compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
US6632961B1 (en) * 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
DK1080070T3 (da) * 1998-05-22 2007-02-26 Abbott Lab Antiangiogent lægemiddel til behandling af cancer, artritis og retinopati
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular
CN1518447A (zh) * 2001-04-23 2004-08-04 �������Ǵ�ѧר������� 作为抗血管生成剂的新的苯邻二甲酰亚胺模拟物的合成和评估
CN100518740C (zh) * 2003-06-06 2009-07-29 阿里克斯股份公司 杂环化合物作为scce抑制剂的制药用途
ES2341545T3 (es) * 2003-06-06 2010-06-22 Arexis Ab Uso de compuestos heterociclicos condensados como inhibidores de scce para el tratamiento de enfermedades de la piel.
ES2581573T3 (es) * 2006-08-08 2016-09-06 Aska Pharmaceutical Co., Ltd. Derivado de quinazolina
MX2009008099A (es) 2007-02-01 2009-12-14 Resverlogix Corp Compuestos para la prevencion y tratamiento de enfermedades cardiovasculares.
CA3146333A1 (en) 2009-03-18 2010-09-23 Resverlogix Corp. Phenyl-quinazolin-4(3h)-one and phenyl-pyrido[2,3-d]pyrimidin-4(3h)-one derivatives and compositions thereof useful as anti-inflammatory agents
PL2421533T3 (pl) 2009-04-22 2019-05-31 Resverlogix Corp Nowe środki przeciwzapalne
EP3268007B1 (en) 2015-03-13 2022-11-09 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
GB201510254D0 (en) * 2015-06-12 2015-07-29 Syngenta Participations Ag Improvements in or relating to organic compounds
JP7427252B2 (ja) 2018-06-27 2024-02-05 株式会社リボルナバイオサイエンス 脊髄性筋萎縮症の予防または治療剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3696102A (en) * 1970-03-09 1972-10-03 Pfizer & Co C Process for the synthesis of substituted quinazolin-4-ones

Also Published As

Publication number Publication date
FR2333511A1 (fr) 1977-07-01
FI64359B (fi) 1983-07-29
CA1084051A (en) 1980-08-19
DK147855C (da) 1985-06-10
JPS5271485A (en) 1977-06-14
CS194786B2 (en) 1979-12-31
IT1050750B (it) 1981-03-20
NO146095C (no) 1982-08-11
GB1523081A (en) 1978-08-31
SE7613588L (sv) 1977-06-06
DE2654215A1 (de) 1977-06-16
DK546776A (da) 1977-06-06
NZ182778A (en) 1978-07-28
JPS5543464B2 (fi) 1980-11-06
IL50849A (en) 1980-11-30
IL50849A0 (en) 1977-01-31
ZA766745B (en) 1977-10-26
AU1947276A (en) 1978-05-18
NO764135L (fi) 1977-06-07
AU505660B2 (en) 1979-11-29
FI64359C (fi) 1983-11-10
ATA894376A (de) 1979-07-15
NO146095B (no) 1982-04-19
US4251531A (en) 1981-02-17
CH626073A5 (fi) 1981-10-30
DK147855B (da) 1984-12-24
FR2333511B1 (fi) 1979-03-02
HU177817B (en) 1981-12-28
SU786894A3 (ru) 1980-12-07
CH626075A5 (fi) 1981-10-30
NL7613450A (nl) 1977-06-07
AT355029B (de) 1980-02-11
BE848696A (fr) 1977-03-16

Similar Documents

Publication Publication Date Title
FI763391A (fi)
FR2316244B1 (fi)
FR2314850B1 (fi)
FR2306911B1 (fi)
JPS5433052Y2 (fi)
JPS554471B2 (fi)
JPS5514610B2 (fi)
JPS51140295U (fi)
JPS51114720U (fi)
JPS5230641U (fi)
JPS5516863Y2 (fi)
JPS5445400Y2 (fi)
JPS553820Y2 (fi)
JPS556662Y2 (fi)
JPS5641387Y2 (fi)
JPS5346451B2 (fi)
JPS5263521U (fi)
JPS5232392U (fi)
JPS5241943U (fi)
JPS51110598U (fi)
CH605664A5 (fi)
BG21746A1 (fi)
CH604547A5 (fi)
CH598737A5 (fi)
CH608298A5 (fi)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: FARMITALIA CARLO ERBA S.P.A